New test may spot fetal chromosome issues weeks earlier than standard methods
NCT ID NCT06523543
First seen Mar 17, 2026 · Last updated May 12, 2026 · Updated 9 times
Summary
This study tests a new, ultra-early, non-invasive method to detect fetal chromosomal abnormalities. Researchers will collect cells from the placenta (extravillous trophoblasts) from 25 pregnant women between 7 and 16 weeks of pregnancy. The goal is to see if this method can provide accurate results earlier than current tests, without harming the pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Montpellier
RECRUITINGMontpellier, France, 34295, France
Contact
Conditions
Explore the condition pages connected to this study.